Description
Practical recommendations for the management of late relapsed and refractory multiple myeloma in 2024
Article: Practical recommendations for the management of late relapsed and refractory multiple myeloma in 2024
€3.03
Related products
-
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart -
Article: INTRODUCTION
€3.03 Add to cart
